rs35982798

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_015512.5(DNAH1):​c.2430C>T​(p.Thr810Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0423 in 1,613,948 control chromosomes in the GnomAD database, including 1,663 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. T810T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.035 ( 134 hom., cov: 33)
Exomes 𝑓: 0.043 ( 1529 hom. )

Consequence

DNAH1
NM_015512.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -5.32

Publications

7 publications found
Variant links:
Genes affected
DNAH1 (HGNC:2940): (dynein axonemal heavy chain 1) This gene encodes an inner dynein arm heavy chain that provides structural support between the radial spokes and the outer doublet of the sperm tail. Naturally occurring mutations in this gene are associated with primary ciliary dyskinesia and multiple morphological anomalies of the flagella that result in asthenozoospermia and male infertility. Mice with a homozygous knockout of the orthologous gene are viable but have reduced sperm motility and are infertile. [provided by RefSeq, Feb 2017]
DNAH1 Gene-Disease associations (from GenCC):
  • spermatogenic failure 18
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • ciliary dyskinesia, primary, 37
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic male infertility due to sperm motility disorder
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 3-52349324-C-T is Benign according to our data. Variant chr3-52349324-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 478430.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-5.32 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0345 (5256/152268) while in subpopulation NFE AF = 0.0465 (3161/68010). AF 95% confidence interval is 0.0451. There are 134 homozygotes in GnomAd4. There are 2417 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 134 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH1NM_015512.5 linkc.2430C>T p.Thr810Thr synonymous_variant Exon 14 of 78 ENST00000420323.7 NP_056327.4 Q9P2D7-4A0A140VJI6
DNAH1XM_017006129.2 linkc.2430C>T p.Thr810Thr synonymous_variant Exon 15 of 80 XP_016861618.1
DNAH1XM_017006130.2 linkc.2430C>T p.Thr810Thr synonymous_variant Exon 15 of 79 XP_016861619.1 Q9P2D7-4A0A140VJI6
DNAH1XM_017006131.2 linkc.2430C>T p.Thr810Thr synonymous_variant Exon 15 of 79 XP_016861620.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH1ENST00000420323.7 linkc.2430C>T p.Thr810Thr synonymous_variant Exon 14 of 78 1 NM_015512.5 ENSP00000401514.2 Q9P2D7-4
DNAH1ENST00000486752.5 linkn.2691C>T non_coding_transcript_exon_variant Exon 14 of 77 2
DNAH1ENST00000497875.1 linkn.2595C>T non_coding_transcript_exon_variant Exon 15 of 21 2

Frequencies

GnomAD3 genomes
AF:
0.0345
AC:
5255
AN:
152150
Hom.:
133
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0137
Gnomad AMI
AF:
0.0866
Gnomad AMR
AF:
0.0461
Gnomad ASJ
AF:
0.0288
Gnomad EAS
AF:
0.0218
Gnomad SAS
AF:
0.0222
Gnomad FIN
AF:
0.0305
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.0465
Gnomad OTH
AF:
0.0416
GnomAD2 exomes
AF:
0.0354
AC:
8821
AN:
249214
AF XY:
0.0357
show subpopulations
Gnomad AFR exome
AF:
0.0141
Gnomad AMR exome
AF:
0.0339
Gnomad ASJ exome
AF:
0.0276
Gnomad EAS exome
AF:
0.0180
Gnomad FIN exome
AF:
0.0326
Gnomad NFE exome
AF:
0.0465
Gnomad OTH exome
AF:
0.0453
GnomAD4 exome
AF:
0.0431
AC:
63040
AN:
1461680
Hom.:
1529
Cov.:
34
AF XY:
0.0428
AC XY:
31101
AN XY:
727128
show subpopulations
African (AFR)
AF:
0.0143
AC:
478
AN:
33480
American (AMR)
AF:
0.0363
AC:
1625
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0283
AC:
739
AN:
26136
East Asian (EAS)
AF:
0.0167
AC:
663
AN:
39700
South Asian (SAS)
AF:
0.0201
AC:
1734
AN:
86258
European-Finnish (FIN)
AF:
0.0335
AC:
1787
AN:
53378
Middle Eastern (MID)
AF:
0.0361
AC:
208
AN:
5768
European-Non Finnish (NFE)
AF:
0.0478
AC:
53119
AN:
1111864
Other (OTH)
AF:
0.0445
AC:
2687
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
3807
7614
11420
15227
19034
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1950
3900
5850
7800
9750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0345
AC:
5256
AN:
152268
Hom.:
134
Cov.:
33
AF XY:
0.0325
AC XY:
2417
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.0136
AC:
566
AN:
41558
American (AMR)
AF:
0.0460
AC:
704
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0288
AC:
100
AN:
3472
East Asian (EAS)
AF:
0.0214
AC:
111
AN:
5176
South Asian (SAS)
AF:
0.0220
AC:
106
AN:
4826
European-Finnish (FIN)
AF:
0.0305
AC:
324
AN:
10610
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.0465
AC:
3161
AN:
68010
Other (OTH)
AF:
0.0435
AC:
92
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
246
493
739
986
1232
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0412
Hom.:
76
Bravo
AF:
0.0355
Asia WGS
AF:
0.0360
AC:
124
AN:
3478
EpiCase
AF:
0.0479
EpiControl
AF:
0.0519

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 09, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spermatogenic failure 18;C4539798:Ciliary dyskinesia, primary, 37 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.052
DANN
Benign
0.47
PhyloP100
-5.3
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35982798; hg19: chr3-52383340; COSMIC: COSV108250758; API